Study on the relationship between intestinal flora and inflammatory bowel disease
基于肠道菌群在炎症性肠病治疗中的关系探究

参考文献 References

[1] Ng Siew C,Shi Hai Yun,Hamidi Nima,et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies.[J].Lancet,2018;390 (10114) : 2769-2778.

[2] Leake SL,Pagni M,Falquet L,et al. The salivary microbiome for differentiating individuals: proof of principle[J].Microbes Infection,2016;18 (6) : 399-405.

[3] Sheehan D, Moran C, Shanahan F. The microbiota in inflamma-tory bowel disease [J].J Gastroenterol,2015;50 (5) : 495-507.

[4] Olszak T, An D, Zeissig S, et al. Microbial Exposure During Early Life Has Persistent Effects on Natural Killer T Cell Function[J].Science,2012;336 (6080) : 489-493.

[5] Hammer HF. Gut microbiota and inflammatory bowel disease[J].Digestive Diseases,2011;29 (6) : 550.

[6] Rigottier-Gois L. Dysbiosis in inflammatory bowel diseases: the oxygen hypothesis[J].ISME J,2013;7 (7) : 1256-1261.

[7] Linskens R K,Huijsdens X W,Savelkoul P H,et al. The bacterial flora in inflammatory bowel disease: current insights in pathogenesis and the influence of antibiotics and probiotics[J].Scandinavian journal of gastroenterology. Supplement,2002; (234) : 292.

[8] Britton GJ, Contijoch EJ, Mogno I, et al. Microbiotas from Humans with Inflammatory Bowel Disease Alter the Balance of Gut Th17 and RORγt+Regulatory T Cells and Exacerbate Colitis in Mice.Immunity,2019;50 (1) : 212-224.

[9] He C, Wang H, Liao WD, et al. Characteristics of mucosa-associated gut microbiota during treatment in Crohn's disease.World J Gastroenterol,2019;25 (18) : 2204-2216.

[10] Lloyd-Price Jason,Arze Cesar, et al. Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases[J].Nature,2019;569 (7758) .

[11] Zhao L, Xiong Q, Stary CM, et al. Bidirectional gut-brain-microbiota axis as a potential link between inflammatory bowel disease and ischemic stroke.J Neuroinflammation,2018;15 (1) : 339.

[12] Koh JH, Kim WU. Dysregulation of gut microbiota and chronic inflammatory disease: from epithelial defense to host immunity.Exp Mol Med,2017;49 (5) : 337.

[13] 涂晶. 益生菌联合美沙拉嗪治疗炎症性肠病的疗效探讨[J].全科口腔医学电子杂志,2019;6 (15) : 128-129.

[14] 王红. 美沙拉嗪与益生菌治疗炎症性肠病的临床疗效[J].航空航天医学杂志,2019;4 (30) : 398-399.

[15] 周洪美,刘秀珍,牟文芝,等. 益生菌联合柳氮磺胺吡啶灌肠治疗溃疡性结肠炎的临床观察[J].中华临床医师杂志,2010;4 (09) : 1671-1672.

[16] 陈娇娇,周莹群. 肠道菌群在炎症性肠病发病机制中作用的研究进展[J].世界临床药物,2019;40 (05) : 324-328.

[17] Valcheva R, Koleva P, Martínez I, et al. nulin-type fructans improve active ulcerative colitis associated with microbiota changes and increased short-chain fatty acids levels.Gut Microbes,2019;10 (3) : 334-357.

[18] 梁金花,郑科文,金大伟. 黄芪多糖对溃疡性结肠炎大鼠肠道菌群调节作用的研究[J].中国中医药科技,2012;19 (4) : 331-332.

[19] 梁金花,孙立群. 探讨中药黄芪多糖对溃疡性结肠炎大鼠肠道菌群失调的调整作用[J].微量元素与健康研究,2013;30 (2) : 1-3.

[20] 温如燕. 通过肠道菌群和Thl7/Treg细胞探讨大黄牡丹汤治疗炎症性肠病的作用机制[D].广州中医药大学,2016; .

[21] 陈珠. 砂仁对炎症性肠病大鼠的治疗作用及其初步机理研究[D].昆明:云南中医学院,2017; : 33-42.

[22] 屈畅. 广藿香醇抗炎症性肠病的代谢组学和肠道菌群分析研究[D].广州中医药大学,2018; .

[23] Burge K, Gunasekaran A, Eckert J, et al. Curcumin and Intestinal Inflammatory Diseases: Molecular Mechanisms of Protection.Int J Mol Sci,2019;20 (8) : 1912.

[24] Pasternak Björn,Svanström Henrik,et al. Use of azathioprine and the risk of cancer in inflammatory bowel disease[J].American journal of epidemiology,2013;177 (11) .

[25] Lemaitre Magali, Kirchgesner Julien. Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory Bowel Disease[J].JAMA,2017;318 (17) : 1679-1686.